Drug Trial Radar · NCT00548340
VEC-162 Study in Adult Patients With Primary Insomnia
Last checked: Nov 19, 2026Latest source record: Oct 15, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
322
Actual
Start
Nov 2007
Primary completion
Feb 2008
Study completion Jun 2008
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 23, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of a 5 week double-blind treatment period of VEC-162 as compared to placebo in male and female patients with primary insomnia.
Conditions
- Primary Insomnia
Interventions
VEC-162 20 mgDrug
20 mg VEC-162 (tasimelteon) capsules, PO daily for five weeks
PlaceboDrug
Placebo capsules, PO daily for five weeks
VEC-162 50 mgDrug
50 mg VEC-162 (tasimelteon) capsules, PO daily for five weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average Change From Baseline - Latency to Persistent Sleep (LPS)Time frame: Baseline, Night 1, and Night 8 measurement
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Vanda Investigational Site
Birmingham, Alabama
Vanda Investigational Site
Hot Springs, Arkansas
Vanda Investigational Site
Little Rock, Arkansas
Vanda Investigational Site
Anaheim, California
Vanda Investigational Site
Burbank, California
Vanda Investigational Site
Los Angeles, California
Vanda Investigational Site
San Diego, California
Vanda Investigational Site
Santa Monica, California
Vanda Investigational Site
Colorado Springs, Colorado
Vanda Investigational Site
Hallandale, Florida
Vanda Investigational Site
Miami, Florida
Vanda Investigational Site
Naples, Florida
Vanda Investigational Site
Orlando, Florida
Vanda Investigational Site
Pembroke Pines, Florida
Vanda Investigational Site
St. Petersburg, Florida
Vanda Investigational Site
Atlanta, Georgia
Vanda Investigational Site
Chicago, Illinois
Vanda Investigational Site
Overland Park, Kansas
Vanda Investigational Site
Crestview Hills, Kentucky
Vanda Investigational Site
Lexington, Kentucky
Vanda Investigational Site
Louisville, Kentucky
Vanda Investigational Site
Chevy Chase, Maryland
Vanda Investigational Site
Newton, Massachusetts
Vanda Investigational Site
Troy, Michigan
Vanda Investigational Site
Chesterfield, Missouri
Vanda Investigational Site
Las Vegas, Nevada
Vanda Investigational Site
New York, New York
Vanda Investigational Site
West Seneca, New York
Vanda Investigational Site
Raleigh, North Carolina
Vanda Investigational Site
Beachwood, Ohio
Vanda Investigational Site
Cincinnati, Ohio
Vanda Investigational Site
Oklahoma City, Oklahoma
Vanda Investigational Site
Columbia, South Carolina
Vanda Investigational Site
Austin, Texas
Vanda Investigational Site
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.